Immunodiagnostic Systems starts sale of Covid antibody test
The AIM-traded firm said the test could now be purchased by customers in the UK, the European Union, and a number of other countries which accept the CE-mark as the basis of regulatory approval.
It said it had started the process of working with a number of national reference centers and governmental bodies, to ensure a roll-out according to national guidelines.
"We are pleased to announce the release to the market of our automated SARS -CoV-2 antibody test, running on the IDS-iSYS analyser," said chief executive officer Jaap Stuut.
"Immunodiagnostic Systems will now seek to commercialise this test via our direct sales force in Europe, and through our extensive distribution network elsewhere, and we look forward to joining the efforts to minimise the impact of the Covid-19 virus."
At 1534 BST, shares in Immunodiagnostic Systems were up 10% at 264p.